These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity]. Matsumoto H; Pietruszewska I; Roguska E Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594 [No Abstract] [Full Text] [Related]
3. Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity. von Knorring L; Perris C; Oreland L; Eisemann M; Holmgren S; Perris H Psychiatry Res; 1985 Aug; 15(4):271-9. PubMed ID: 3865245 [TBL] [Abstract][Full Text] [Related]
4. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder]. Lin Y Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991 [TBL] [Abstract][Full Text] [Related]
6. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population. Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472 [TBL] [Abstract][Full Text] [Related]
10. Blood platelets as a model system for studying the biochemistry of depression. Lingjaerde O Adv Biochem Psychopharmacol; 1984; 39():99-111. PubMed ID: 6087630 [No Abstract] [Full Text] [Related]
11. Platelet MAO activity in clinical subtypes of depression and DST suppression. Poirier MF; Lôo H; Mitrani N; Benkelfat C; Askienazy S; Le Fur G Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729 [TBL] [Abstract][Full Text] [Related]
13. [Significance of various enzymes of mediator metabolism for evaluation of depression and therapeutic prognosis]. Vertogradova OP; Misionzhinik EIu; Poliakov SE; Uzbekov MG Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):99-103. PubMed ID: 1319664 [TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase in an aged general population and elderly chronic schizophrenics [[proceedings]. Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ Psychopharmacol Bull; 1981 Jan; 17(1):103-4. PubMed ID: 7232634 [No Abstract] [Full Text] [Related]
16. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
17. Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report. Leckman JF; Gershon ES; Nichols AS; Murphy DL Arch Gen Psychiatry; 1977 May; 34(5):601-6. PubMed ID: 871234 [TBL] [Abstract][Full Text] [Related]
18. [Platelet monoamine oxidase and sex hormones in a population of depressed patients]. Poirier MF; Lôo H; Lefur G; Mitrani N Encephale; 1985; 11(3):125-9. PubMed ID: 4029076 [TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase in affective illness and alcoholism. Belmaker RH; Bracha HS; Ebstein RP Schizophr Bull; 1980; 6(2):320-3. PubMed ID: 7375864 [TBL] [Abstract][Full Text] [Related]
20. Relationship of platelet MAO activity to characteristics of major depressive illness. Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]